On October 31, 2017, Shenzhen AIVD Biotechnology Co., Ltd. passed the national high-tech enterprise recognition organized by Shenzhen Science and Technology Innovation Committee, Shenzhen Finance Committee, Shenzhen State Taxation Bureau and Shenzhen Local Taxation Bureau, thus officially stepping into the ranks of national high-tech enterprises.

This successful selection as a national high-tech enterprise fully illustrates the affirmation of the relevant national departments to AIVD's various work, and also becomes an important symbol of our company's technical level and the qualitative technical content of our products.

"National High-tech Enterprise" refers to the enterprise that continuously carries out research and development and transformation of technical achievements in the high-tech field supported by the state, forms the core independent intellectual property rights of the enterprise, and carries out business activities on this basis, and transforms the major high-tech achievements into productivity at a technical level that belongs to the domestic leading or international advanced The enterprise is one of the leading or internationally advanced enterprises in China. The title of "National High-tech Enterprise" is a milestone of AIVD's technical level and product technology content.

According to the relevant provisions of the revised "High and New Technology Enterprise Recognition Management Measures" issued by the State Science and Technology Development and Fire [2016] No. 32, our company was finally recognized as a national "High and New Technology Enterprise" after strict declaration procedures such as company declaration, local preliminary examination, expert review and public announcement. This recognition provides favorable policy support for the company to enjoy enterprise tax benefits, project bidding and government funding in the future.

Since its establishment in 2014, Shenzhen AIVD Biotechnology Co., Ltd. has been insisting on innovation and research, and has obtained a number of research and development patents, and many other innovations are being verified.

The evaluation of national high-tech enterprise is a great encouragement to AIVD from national and provincial and municipal science and technology, finance and taxation departments. In the future, AIVD will pay more attention to independent innovation, protect intellectual property rights, strengthen brand building and enhance the core competitiveness of the enterprise; it will also continue to increase the investment in scientific research, enrich the innovation development of the enterprise and enhance the transformation ability of scientific and technological achievements; provide strong technical support for the sustainable and rapid development of the enterprise and strive to become the backbone of leading the development of the biopharmaceutical industry.

About AIVD

AIVD is a China high-tech enterprise specialized in providing overall technical solutions for global in vitro diagnostic reagent manufacturers. The core team members have rich experience in product development, manufacturing and registration. There are more than 100 members, among which more than 70% of the R&D staff are composed of PhD, master and undergraduate students. The existing site area is 5000 square meters, including 3000 square meters for R&D and 2000 square meters for production. Our products cover multiple platforms such as enzyme immunoassay, colloidal gold, fluorescence chromatography, chemiluminescence, immunoturbidimetry and molecular diagnostics. Avidi provides a full set of technical solutions for customers with professional and high quality services, including custom development of raw materials to OEM production; custom development of finished reagents to bulk packaging production; optimization of products to production processes. Since the establishment of the company, the team has successfully delivered a number of first-of-its-kind diagnostic reagents in China, and partially achieved the localization of imported raw materials.